Legionella Pneumophila

• USES: • For the temporary relief of symptoms including: • mucus congestion • stomach discomfort • fever • headache • cough • joint discomfort • occasional diarrhea • bladder discomfort These statements are based upon homeopathic principles. They have not been reviewed by the Food and Drug Administration.ICD-10: R05.9, R51.9

DIRECTIONS: 1-10 drops under the tongue, 3 times a day or as directed by a health professional. Consult a physician for use in children under 12 years of age.

If pregnant or breast-feeding, ask a health professional before use. Keep out of reach of children. In case of overdose, contact a physician or Poison Control Center right away. Tamper Evident: Sealed for your protection. Do not use if seal is broken or missing.

Recent PubMed references pinned to Legionella Pneumophila as a MeSH major topic. Citations link to pubmed.ncbi.nlm.nih.gov.

• Polyphosphates Attenuate Interleukin-12 Production in Macrophages Infected With Legionella pneumophila.
  FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2026 · Vasilew K, Jayaraman A, Platten J, et al.
  PMID 42219888DOI 10.1096/fj.202502405RRR
• Serum Endotoxin as a Diagnostic Biomarker for Legionella pneumophila in Gram-Negative Infections.
  Journal of visualized experiments : JoVE · 2026 · Li Y, Lin L, Chen M, et al.
  PMID 42149796DOI 10.3791/70502
• Exploring the distribution of Legionella pneumophila sequence types in the water supply system of Klang Valley integrated transit system.
  The Malaysian journal of pathology · 2026 · Wong JL, Ngeow YF, Yap SF, et al.
  PMID 42059168
• Major type IV pilin of Legionella pneumophila enhances bacterial iron acquisition/assimilation, independently of its role in piliation.
  mBio · 2026 · Barajas A, Mayoral J, Cianciotto NP, et al.
  PMID 42029019DOI 10.1128/mbio.00596-26
• Manipulation of nonclassical ubiquitin signaling by pathogenic bacteria.
  Current opinion in microbiology · 2026 · Kaur Sidhu J, Kubori T, Pruneda JN, et al.
  PMID 42013603DOI 10.1016/j.mib.2026.102756
• Mechanism of Legionella pneumophila-induced liver injury via gut microbiota translocation under immunosuppression.
  Pathology, research and practice · 2026 · Lu D, Ping C, Jia D, et al.
  PMID 41921236DOI 10.1016/j.prp.2026.156456
• Structural insights into SetA-mediated Rab1 glucosylation and PI3P-guided localization during early Legionella infection.
  Proceedings of the National Academy of Sciences of the United States of America · 2026 · Im HN, Lee Y, Song Y, et al.
  PMID 41894332DOI 10.1073/pnas.2535016123
• Localization of the PelC and PelE effectors to the Legionella-containing vacuole through host-mediated prenylation and their role in intracellular proliferation.
  Infection and immunity · 2026 · Shin CJ, Price CTD, Da'as MSJ, et al.
  PMID 41874000DOI 10.1128/iai.00605-25

The 8 most recently updated of 8 ClinicalTrials.gov registrations naming Legionella Pneumophila as an intervention. Registration is not evidence of efficacy or safety — reference crosswalk only.

• Curian S. Pneumo/Legionella Assay Beta Clinical Trial Protocol
  Completed · Observational · 199 enrolled · Meridian Bioscience, Inc.
  NCT05681156updated 2025-01-29
• Impact of Comprehensive Molecular Tests on Antimicrobial Stewardship in Community-acquired Pneumonia
  Terminated · Interventional · 242 enrolled · Hospital Universitari de Bellvitge
  NCT04158492updated 2023-04-28
• Nosocomial and Community Acquired Legionella Pneumophila Pneumonia.
  Completed · Observational · 46 enrolled · Dr Philippe CLEVENBERGH
  NCT04106037updated 2022-07-20
• A Clinical Study on Qianjin Capsule of Gynaecology Combined With Antibiotics for Pelvic Inflammatory Diseases (Damp-heat Stasis and Qi Deficiency Syndrome)
  Unknown · Phase 4 · Interventional · 184 enrolled · China Academy of Chinese Medical Sciences
  NCT04031664updated 2019-07-31
• Impact of Legionella Urine Antigen Testing (LUAT) on the Local Epidemiology and Diagnosis of Legionella Pneumonia
  Completed · Observational · 505 enrolled · Ministry of Health, Malaysia
  NCT03200275updated 2019-07-30
• A Clinical Study on Kangfu Anti-inflammatory Suppository of Gynaecology Combined With Antibiotics for Pelvic Inflammatory Diseases (Evidence of Dampness and Heat Accumulation)
  Unknown · Phase 4 · Interventional · 240 enrolled · China Academy of Chinese Medical Sciences
  NCT04035785updated 2019-07-29
• Procalcitonin Antibiotic Consensus Trial (ProACT)
  Completed · Interventional · 1,664 enrolled · University of Pittsburgh
  NCT02130986updated 2019-01-15
• Special Investigation Of Azithromycin IV For Legionnaires' Disease (Regulatory Post Marketing Commitment Plan)
  Completed · Observational · 21 enrolled · Pfizer
  NCT01784770updated 2017-11-30

Frequently asked questions

What is Legionella Pneumophila used for?

According to FDA labeling, Legionella Pneumophila carries indications including: USES: • For the temporary relief of symptoms including: • mucus congestion • stomach discomfort • fever • headache • cough • joint discomfort • occasional diarrhea • bladder discomfort These statements are based upon homeopathic principles. They have not been reviewed by the Food and Drug Administration.. This is a reference summary of labeled uses, not medical advice or a treatment recommendation.